...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Two big thank you’s

Nov 24, 2022 01:46PM
2
Nov 24, 2022 03:49PM

Nov 24, 2022 04:33PM
5
Nov 24, 2022 05:54PM

RVXOT - ZHCLF has the same CUSIP number as the shares I received in the spin out so there is no differentiation. As for valuation, we'll cross that bridge when/if we get there.

tada 

2
Nov 24, 2022 07:53PM
2
Nov 24, 2022 07:55PM
2
Nov 24, 2022 08:40PM

Nov 24, 2022 08:53PM
3
Nov 24, 2022 09:26PM
2
Nov 25, 2022 07:18AM
2
Nov 25, 2022 12:40PM
1
Nov 25, 2022 02:23PM
Share
New Message
Please login to post a reply